Serpin G1

Serpin G1

Serpin G1 Molekülinformation

Molecule Name
Plasma protease C1 inhibitor
Molekülalias
SERPING1,C1IN,C1-INH,C1IN,HAE1,HAE2
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
C1 Inh,C1Inh,C1 esterase inhibitor,C1-inhibiting factor,Serpin G1,Serpin Family G Member 1
Molekülhintergrund
Serpin G1/C1-inhibitor (C1-INH) is an important regulator of the complement, coagulation, fibrinolytic and contact systems. The quantity of protease/C1-INH complexes in the blood is proportional to the level of the in vivo activation of these four cascade-like plasma enzyme systems. It inhibits activated C1r and C1s of the first complement component and thus regulates complement activation. It is synthesized in the liver, and its deficiency is associated with hereditary angioneurotic oedema (HANE).

Serpin G1 Produktliste

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
BMN-331BMN 331; BMN-331Phase 2 ClinicalBiomarin Pharmaceutical Inc
Angioedemas, Hereditary
Details